LONG-TERM EFFICACY AND SAFETY OF OBETICHOLIC ACID IN PRIMARY BILIARY CHOLANGITIS: RESPONDER ANALYSIS OF OVER 5 YEARS OF TREATMENT IN THE POISE TRIAL
Hansen BE, Jones D, Carbone M, Bowlus CL, Nevens F, Kremer A, Liberman A, Macconell L, Hirschfield GM (2020)
Publication Type: Conference contribution
Publication year: 2020
Journal
Publisher: WILEY
City/Town: HOBOKEN
Pages Range: 752A-752A
Conference Proceedings Title: HEPATOLOGY
Authors with CRIS profile
Involved external institutions
University Hospital Leuven (UZ) / Universitaire ziekenhuizen Leuven
Belgium (BE)
University of Toronto
Canada (CA)
University Health Network (UHN)
Canada (CA)
University of Milano-Bicocca / Università degli Studi di Milano-Bicocca, UNIMIB
Italy (IT)
University of California Davis (UCDAVIS)
United States (USA) (US)
Newcastle University
United Kingdom (GB)
Intercept Pharmaceuticals
United States (USA) (US)
Belgium (BE)
University of Toronto
Canada (CA)
University Health Network (UHN)
Canada (CA)
University of Milano-Bicocca / Università degli Studi di Milano-Bicocca, UNIMIB
Italy (IT)
University of California Davis (UCDAVIS)
United States (USA) (US)
Newcastle University
United Kingdom (GB)
Intercept Pharmaceuticals
United States (USA) (US)
How to cite
APA:
Hansen, B.E., Jones, D., Carbone, M., Bowlus, C.L., Nevens, F., Kremer, A.,... Hirschfield, G.M. (2020). LONG-TERM EFFICACY AND SAFETY OF OBETICHOLIC ACID IN PRIMARY BILIARY CHOLANGITIS: RESPONDER ANALYSIS OF OVER 5 YEARS OF TREATMENT IN THE POISE TRIAL. In HEPATOLOGY (pp. 752A-752A). HOBOKEN: WILEY.
MLA:
Hansen, Bettina E., et al. "LONG-TERM EFFICACY AND SAFETY OF OBETICHOLIC ACID IN PRIMARY BILIARY CHOLANGITIS: RESPONDER ANALYSIS OF OVER 5 YEARS OF TREATMENT IN THE POISE TRIAL." Proceedings of the Liver Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) HOBOKEN: WILEY, 2020. 752A-752A.
BibTeX: Download